Publikationen, an denen er mitarbeitet María Villa Morales (11)

2023

  1. Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  2. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

2022

  1. A Dual Role for FADD in Human Precursor T-Cell Neoplasms

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2019

  1. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma

    Scientific Reports, Vol. 9, Núm. 1

  2. Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma

    Oncogene, Vol. 38, Núm. 23, pp. 4620-4636

  3. S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma

    Carcinogenesis, Vol. 40, Núm. 10, pp. 1260-1268

2015

  1. Role of cannabinoid receptor CB<inf>2</inf> in HER2 pro-oncogenic signaling in breast cancer

    Journal of the National Cancer Institute, Vol. 107, Núm. 6

2009

  1. A role for auxiliary TGF-beta receptor endoglin as a modulator of tumor progression

    EJC SUPPLEMENTS

2007

  1. A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas

    Cancer Research, Vol. 67, Núm. 11, pp. 5107-5116

  2. A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis

    Cancer Research, Vol. 67, Núm. 21, pp. 10268-10277

  3. A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomas

    EJC SUPPLEMENTS